Zaloguj Zarejestruj się zadarmo

Varian Medical Systems organizacji Zwrot z kapitału

Jaka jest wartość Zwrot z kapitału organizacji Varian Medical Systems?

Wartość Zwrot z kapitału organizacji Varian Medical Systems, Inc. to 13.69%

Jaka jest definicja Zwrot z kapitału?



Wskaźnik rentowności kapitału (Return on equity - ROE) jest miarą rentowności działalności gospodarczej w stosunku do wartości księgowej kapitału własnego. Oblicza się ją przez podzielenie dochodu netto roku obrotowego przez całkowity kapitał własny akcjonariusza.

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Zwrot z kapitału firm w Miscellaneous sektor na LSE w porównaniu do Varian Medical Systems

Czym się zajmuję organizacja Varian Medical Systems?

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates in Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with Siemens AG; partnership agreement with The National University Cancer Institute; and a strategic collaboration with Telix Pharmaceuticals for advanced prostate imaging. Varian Medical Systems was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.

Firmy z zwrot z kapitału podobne do Varian Medical Systems